UK markets closed

Tryp Therapeutics Inc. (TRYPF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0562+0.0137 (+32.24%)
At close: 03:17PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CAD. All numbers in thousands
Breakdown
ttm
31/08/2023
31/08/2022
31/08/2021
31/08/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,669
2,356
2,964
1,281
8.327
Selling general and administrative
2,389
2,368
4,400
6,007
414.29
Total operating expenses
4,059
4,724
7,364
7,288
422.617
Operating income or loss
-4,059
-4,724
-7,364
-7,288
-422.617
Total other income/expenses net
-36.141
-22.417
-134.149
-977.533
-
Income before tax
-4,793
-5,267
-7,495
-8,255
-422.617
Income from continuing operations
-4,793
-5,267
-7,495
-8,255
-422.617
Net income
-4,793
-5,267
-7,495
-8,255
-422.617
Net income available to common shareholders
-4,793
-5,267
-7,495
-8,255
-422.617
Basic EPS
-0.05
-0.05
-0.10
-0.14
-0.01
Diluted EPS
-0.05
-0.05
-0.10
-0.14
-0.01
Basic average shares
96,419
96,419
78,065
57,512
66,320
Diluted average shares
96,419
96,419
78,065
57,512
66,320